tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Athira Pharma: Hold Rating Amid Strategic Uncertainty and Resource Challenges
PremiumRatingsAthira Pharma: Hold Rating Amid Strategic Uncertainty and Resource Challenges
6M ago
Athira Pharma’s Strategic Focus on ATH-1105 Amidst Uncertainties: Hold Rating Maintained
Premium
Ratings
Athira Pharma’s Strategic Focus on ATH-1105 Amidst Uncertainties: Hold Rating Maintained
6M ago
Athira Pharma’s 2024 Financial Results and Pipeline Progress
Premium
Company Announcements
Athira Pharma’s 2024 Financial Results and Pipeline Progress
6M ago
Athira Pharma Reports Q3 2024 Financial Results
PremiumCompany AnnouncementsAthira Pharma Reports Q3 2024 Financial Results
10M ago
Athira Pharma reports Q3 EPS (75c), consensus (71c)
Premium
The Fly
Athira Pharma reports Q3 EPS (75c), consensus (71c)
10M ago
3 Penny Stocks to Watch Now, 11/5/24
Premium
Market News
3 Penny Stocks to Watch Now, 11/5/24
10M ago
Goldman Sachs moves Athira Pharma to Not Rated
PremiumThe FlyGoldman Sachs moves Athira Pharma to Not Rated
1y ago
Athira Pharma downgraded to Neutral from Buy at Rodman & Renshaw
Premium
The Fly
Athira Pharma downgraded to Neutral from Buy at Rodman & Renshaw
1y ago
Athira Pharma downgraded to Market Perform from Outperform at JMP Securities
Premium
The Fly
Athira Pharma downgraded to Market Perform from Outperform at JMP Securities
1y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100